Compare BLTE & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | ENVA |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.9B |
| IPO Year | 2022 | N/A |
| Metric | BLTE | ENVA |
|---|---|---|
| Price | $169.05 | $164.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $161.57 | ★ $162.71 |
| AVG Volume (30 Days) | 237.7K | ★ 280.1K |
| Earning Date | 03-16-2026 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.05 |
| EPS | N/A | ★ 11.52 |
| Revenue | N/A | ★ $1,490,936,000.00 |
| Revenue This Year | N/A | $150.85 |
| Revenue Next Year | N/A | $15.16 |
| P/E Ratio | ★ N/A | $13.82 |
| Revenue Growth | N/A | ★ 20.33 |
| 52 Week Low | $49.00 | $79.41 |
| 52 Week High | $174.78 | $168.68 |
| Indicator | BLTE | ENVA |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 60.08 |
| Support Level | $156.52 | $153.70 |
| Resistance Level | $171.63 | $164.00 |
| Average True Range (ATR) | 8.88 | 4.92 |
| MACD | 0.26 | -0.54 |
| Stochastic Oscillator | 79.00 | 78.87 |
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.